Invitae
ISIN US46185L1035
|WKN A14NKG
Overview
Description
Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.
Healthcare Healthcare Services Patient Care United States
Financials
Key metrics
| Market capitalisation, EUR | 4.29 m |
| EPS, EUR | -5.04 |
| P/B ratio | 2.28 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2022)
| Revenue, EUR | 490.98 m |
| Net income, EUR | -2,953.94 m |
| Profit margin | -601.64% |
What ETF is Invitae in?
There is 1 ETF which contains Invitae.
| ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
|---|---|---|---|---|---|---|---|---|
| HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF | 0.54% | Equity World Health Care Equal Weighted Innovation | 217 | 0.59% | 14 | -8.70% | A2PFPC | IE00BJQTJ848 |
Savings plan offers
Here you can find information about the savings plan availability for the stock. You can use the table to compare savings plan offers for the selected savings rate.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.